Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Caribou Biosciences, Inc. | Chief Financial Officer | Option to purchase Common Stock | 153K | $352K | $2.69 | Feb 20, 2024 | Direct |
Caribou Biosciences, Inc. | Chief Financial Officer | Common Stock | 59.2K | $159K | $2.69 | Feb 20, 2024 | Direct |
Vir Biotechnology, Inc. | EVP & Chief Financial Officer | Common Stock | 0 | $0 | $7.80 | Oct 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VIR | Vir Biotechnology, Inc. | Oct 2, 2024 | 0 | $0 | 3 | Oct 3, 2024 | EVP & Chief Financial Officer |
CRBU | Caribou Biosciences, Inc. | Feb 20, 2024 | 2 | $0 | 4 | Feb 22, 2024 | Chief Financial Officer |
CRBU | Caribou Biosciences, Inc. | Feb 21, 2023 | 1 | $0 | 4 | Feb 23, 2023 | Chief Financial Officer |
CRBU | Caribou Biosciences, Inc. | Feb 8, 2022 | 2 | $100K | 4 | Feb 8, 2022 | Chief Financial Officer |
CRBU | Caribou Biosciences, Inc. | Dec 20, 2021 | 1 | $0 | 4 | Dec 21, 2021 | Chief Financial Officer |
CRBU | Caribou Biosciences, Inc. | Jul 22, 2021 | 0 | $0 | 3 | Jul 22, 2021 | Chief Financial Officer Exhibit 24 - Power of Attorney. |